RE: Forbes Article - New Evidence Of Immune Suppression By SARS-CoV-230 Dec 2021 10:07
Ndn71, ACTIV-2 might give us two bites at the cherry, but I still struggle to see how, if we fail SPRINTER P3, that we’d pass ACTIV P3, when in Synairgen’s own words the hospitalised patients are better for us where “we have a fire to put out”? Certainly the odds would be against us.
Let’s hope it doesn’t come to that, and we pass SPRINTER with flying colours.